Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accumulated Expenses (2023 - 2026)

Camp4 Therapeutics' Accumulated Expenses history spans 3 years, with the latest figure at $5.6 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 16.53% to $5.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.6 million, a 16.53% increase, with the full-year FY2025 number at $5.6 million, up 16.53% from a year prior.
  • Accumulated Expenses hit $5.6 million in Q4 2025 for Camp4 Therapeutics, up from $4.1 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for CAMP hit a ceiling of $5.6 million in Q4 2025 and a floor of $1.8 million in Q1 2025.
  • Historically, Accumulated Expenses has averaged $3.7 million across 3 years, with a median of $3.7 million in 2024.
  • Biggest five-year swings in Accumulated Expenses: soared 46.37% in 2024 and later rose 10.55% in 2025.
  • Tracing CAMP's Accumulated Expenses over 3 years: stood at $3.3 million in 2023, then soared by 46.37% to $4.8 million in 2024, then rose by 16.53% to $5.6 million in 2025.
  • Business Quant data shows Accumulated Expenses for CAMP at $5.6 million in Q4 2025, $4.1 million in Q3 2025, and $2.9 million in Q2 2025.